|
- Gene, Cell, + RNA Therapy Landscape Report - asgct. org
The field earned the approval of three new therapies—a CAR-T therapy for myeloma in China, an AAV gene therapy for hemophilia B in Canada, and an autologous cell therapy for melanoma in the United States Excitingly, there are now more than 4,000 gene, cell, and RNA therapies in development
- 2024 Breakthrough: 9 New Cell and Gene Therapies Approvals
These therapies include stem cell therapies, gene therapies, and CAR-T therapies Five of the 9 approvals occurred in the last 2 months of the year Read more below about these approved CGT therapies and their indications FIG 1 CGT Approved Products in 2024
- Updated 2025 List of FDA-Approved Cell and Gene Therapies
Professor's list of FDA-approved cell and gene therapies including stem cell therapies that have received FDA approval
- Approval and therapeutic value of gene therapies in the US and . . . - Nature
To better understand the clinical importance of the current landscape of approved gene therapies, we conducted a systematic analysis of the approved gene therapies and their added therapeutic value
- FDA Cell Gene Therapy Approvals 2024 - pharmaboardroom. com
The list of therapies to reach the finish line in 2024 included a number of firsts Iovance Biotherapeutics’s Amtagvi was the first one-time T cell therapy for solid tumor cancer and the first treatment option for adults with advanced melanoma after anti-PD-1 and targeted therapy
- From the Editors: Cell Gene Therapy Approvals in 2024
The first 2024 gene therapy approval was on 25 April Fidanacogene elaparvovec-dzkt (Beqvez) from Pfizer, Inc was approved for the treatment of adults with moderate to severe hemophilia B (congenital factor IX deficiency)
- The Gene Cell Therapy Landscape: Recent Approvals and Upcoming . . .
Here we take a glance at the recent advancements in therapy approvals and clinical developments across various disease areas, highlighting recent advancements in gene, cell, and RNA therapies, along with breakthroughs in hematology, neurodegenerative disorders, genetic diseases, and blood disorders
- How Many Gene Therapies Are FDA Approved? | Unlocking Potential
What are the current FDA-approved gene therapies? As of October 2023, there are 19 FDA-approved gene therapies These therapies target various genetic disorders and conditions, showcasing the advancements in genetic medicine Each therapy is designed to address specific diseases, providing options for patients who previously had limited treatment alternatives
|
|
|